• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Influenza Virus Vaccine for the 2008-2009 Season

2008/2009 Season Lot Release Status (as of December 17, 2008)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers.

For information on flu vaccine distribution schedules, please contact the manufacturers directly.

Manufacturer Total Number of Lots Released by FDA
Afluria
CSL Limited
Parkville
Victoria, Australia
License 1764
42
Fluarix
GlaxoSmithKline Biologicals
Rue de l'Institut 89
B1330 Rixensart Belgium
License 1617
28
Flulaval
ID Biomedical Corporation of Quebec
525 Cartier Blvd, West
Laval, Quebec 87V 3S8 Canada
License 1739
42
FluMist
MedImmune
297 North Bernardo Ave
Mountain View, CA 94043
License 1652
45
Fluvirin
Novartis Vaccine
Gaskill Road, Speke
Liverpool L24 9GR
United Kingdom
License 1750
48
Fluzone
Sanofi Pasteur Inc
Discovery Drive
Swiftwater, PA 18370
License 1725
86

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Gaithersburg, Maryland, on February 21, 2008, to select the influenza virus strains for the composition of the influenza vaccine for use in the 2008-2009 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics, serological responses to 2007/2008 vaccines, and the availability of candidate strains and reagents.

The panel recommended that vaccines to be used in the 2008-2009 influenza season in the U.S. contain the following:

  • an A/Brisbane/59/2007 (H1N1)-like virus;
  • an A/Brisbane/10/2007 (H3N2)-like virus; *
  • a B/Florida/4/2006-like virus. #
  • * A/Brisbane/10/2007 is a current southern hemisphere vaccine virus.
    #B/Florida/4/2006 and B/Brisbane/3/2007 (a B/Florida/4/2006-like virus) are current southern hemisphere vaccine viruses.

The influenza vaccine composition to be used in the 2008-2009 influenza season in the U.S. is identical to that recommended by the World Health Organization on February 14, 2008, for the Northern Hemisphere's 2008-2009 influenza season.

 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002